The Discounted Cash Flow (DCF) valuation of Abbott Laboratories (ABT) is 113.99 USD. With the latest stock price at 97.50 USD, the upside of Abbott Laboratories based on DCF is 16.9%.
Based on the latest price of 97.50 USD and our DCF valuation, Abbott Laboratories (ABT) is a buy. buying Abbott stocks now will result in a potential gain of 16.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.4% | 7.4% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 73.08 - 239.25 | 113.99 |
| Upside | -25.0% - 145.4% | 16.9% |